Document is current
Any future updates will be listed below
-
Authors
An, Luye
Kim, Dahihm http://orcid.org/0000-0002-6153-1898
Donahue, Leanne R. http://orcid.org/0000-0001-6289-8053
Mejooli, Menansili Abraham
Eom, Chi-Yong
Nishimura, Nozomi http://orcid.org/0000-0003-4342-9416
White, Andrew C. http://orcid.org/0000-0002-5436-5377
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (5R01AR075755)
Cornell University Stem Cell Program Cornell University Center for Vertebrate Genomics
- License Information
-
More Information
Article History
Received: 23 May 2023
Accepted: 12 January 2024
First Online: 27 January 2024
Competing interests
: The corresponding author declares the following competing interests: Patent applicant: Cornell University. Name of the inventor: Andrew White. Application number: 63/496,967. Status of application: Pending. Specific aspect of manuscript covered in patent application: Figure 7, use of pge2 analog with uvb and uvb+ruxolitinib. The remaining authors declare no competing interests.
